New deep-learning framework identifies non-addictive pain relief options

FHS
October 7, 2024
10:57 am

An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired.

Everise Acquires CGS Healthcare Vertical, Expands US Footprint and Service Offerings

What You Should Know: – Everise, a global leader in healthcare customer experience (CX), today announced its acquisition of Continuum Global Solutions’ (CGS) healthcare vertical

September 25, 2024

BioMarin touts Voxzogo sales bump in Q2 results, notes ‘temporarily tight supply’

BioMarin is touting “record revenues” from the first half of 2023, spearheaded by the jump in sales of its achondroplasia drug Voxzogo — so much

August 2, 2023

Health Canada approves Novo Nordisk’s Wegovy

Wegovy is available in more than ten countries. Credit: CNW Group/Novo Nordisk Canada Inc. Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it

November 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.